Compare commits

..

3 commits

Author SHA1 Message Date
Teleo Agents
fbd338c7ec auto-fix: strip 2 broken wiki links
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
2026-03-16 11:21:12 +00:00
Teleo Agents
f84a6885c4 extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage 2026-03-16 11:19:29 +00:00
Teleo Agents
862c52e732 entity-batch: update 2 entities
- Applied 3 entity operations from queue
- Files: entities/internet-finance/futardio.md, entities/internet-finance/metadao.md

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
2026-03-16 11:19:12 +00:00
11 changed files with 18 additions and 55 deletions

View file

@ -43,7 +43,7 @@ The claim that budget scoring "systematically" undervalues prevention requires e
### Additional Evidence (confirm)
*Source: [[2024-11-01-aspe-medicare-anti-obesity-medication-coverage]] | Added: 2026-03-16*
The CBO vs. ASPE divergence on Medicare GLP-1 coverage provides concrete evidence: CBO projects $35B in additional spending (2026-2034) using budget scoring methodology, while ASPE projects net savings of $715M over 10 years using clinical economics methodology that includes downstream event avoidance. The $35.7B gap between these estimates demonstrates how budget scoring rules structurally disadvantage preventive interventions. CBO uses conservative uptake assumptions and doesn't fully count avoided hospitalizations and disease progression within the 10-year window, while ASPE includes 38,950 CV events avoided and 6,180 deaths avoided. Both are technically correct but answer different questions—budget impact vs. clinical economics.
CBO scored Medicare GLP-1 coverage at $35B additional spending over 2026-2034, while ASPE clinical economics analysis found net savings of $715M over 10 years from the same policy. The $35.7B divergence stems from CBO's conservative assumptions about uptake rates and limited counting of downstream savings (avoided hospitalizations, disease progression) within the 10-year budget window. ASPE's model includes 38,950 cardiovascular events avoided and 6,180 deaths avoided, which generate healthcare cost offsets that CBO methodology structurally undercounts.
---

View file

@ -30,6 +30,12 @@ For value-based care models and capitated payers, this multi-organ protection cr
- Nature Medicine: additive benefits with SGLT2 inhibitors
- First GLP-1 to receive FDA indication for CKD in T2D patients
### Additional Evidence (confirm)
*Source: [[2024-11-01-aspe-medicare-anti-obesity-medication-coverage]] | Added: 2026-03-16*
ASPE's broad semaglutide access scenario projects 38,950 cardiovascular events avoided and 6,180 deaths avoided over 10 years among Medicare beneficiaries. The eligibility criteria require comorbidities (CVD history, heart failure, CKD, prediabetes) rather than BMI alone, targeting the population where multi-organ protection creates the highest clinical value. Approximately 10% of Medicare beneficiaries would be eligible under these criteria.
---
Relevant Notes:

View file

@ -34,12 +34,6 @@ Rated experimental because this is a proposed design not yet deployed. The liqui
Coal's v0.6 migration sets minimum liquidity requirements of 1500 USDC and 2000 coal for proposals, with OTC buyer lined up to purchase dev fund tokens and seed the futarchy AMM. This shows the liquidity bootstrapping pattern extends beyond initial launch to governance upgrades, where projects must arrange capital to meet minimum depth requirements before migration.
### Additional Evidence (confirm)
*Source: [[2024-01-24-futardio-proposal-develop-amm-program-for-futarchy]] | Added: 2026-03-16*
The proposal describes the bootstrapping mechanism: 'These types of proposals would also require that the proposer lock-up some initial liquidity, and set the starting price for the pass/fail markets. With this setup, liquidity would start low when the proposal is launched, someone would swap and move the AMM price to their preferred price, and then provide liquidity at that price since the fee incentives are high. Liquidity would increase over the duration of the proposal.'
---
Relevant Notes:

View file

@ -21,12 +21,6 @@ This cost differential becomes material at scale: a DAO running 50 proposals ann
- AMM state requirements described as "almost nothing"
- State rent recovery requires autocrat program migration (feedback section)
### Additional Evidence (confirm)
*Source: [[2024-01-24-futardio-proposal-develop-amm-program-for-futarchy]] | Added: 2026-03-16*
MetaDAO proposal CF9QUBS251FnNGZHLJ4WbB2CVRi5BtqJbCqMi47NX1PG quantifies the cost reduction: CLOB market pairs cost 3.75 SOL in state rent per proposal (135-225 SOL annually at 3-5 proposals/month), while AMMs cost 'almost nothing' in state rent. At January 2024 SOL prices ($85), this represents $11,475-$19,125 annual savings.
---
Relevant Notes:

View file

@ -23,12 +23,6 @@ This connects to [[MetaDAOs futarchy implementation shows limited trading volume
- Expected pattern: liquidity increases as proposal duration progresses
- CLOB minimum order size (1 META) acts as spam filter but fragments liquidity further
### Additional Evidence (confirm)
*Source: [[2024-01-24-futardio-proposal-develop-amm-program-for-futarchy]] | Added: 2026-03-16*
The proposal identifies that 'estimating a fair price for the future value of MetaDao under pass/fail conditions is difficult, and most reasonable estimates will have a wide range. This uncertainty discourages people from risking their funds with limit orders near the midpoint price, and has the effect of reducing liquidity (and trading).' This is cited as 'the main reason for switching to AMMs.'
---
Relevant Notes:

View file

@ -36,12 +36,6 @@ The mechanism depends on futarchy-specific conditions (short duration, governanc
- May reduce legitimate trading volume
- LP attraction depends on base trading activity
### Additional Evidence (confirm)
*Source: [[2024-01-24-futardio-proposal-develop-amm-program-for-futarchy]] | Added: 2026-03-16*
MetaDAO's AMM proposal sets fees at 3-5% explicitly to 'both: encourage LPs, and aggressively discourage wash-trading and manipulation.' The mechanism works because high fees make price manipulation through wash trading expensive while creating strong incentives for liquidity provision.
---
Relevant Notes:

View file

@ -30,12 +30,6 @@ The proposal acknowledges CLOB manipulation is "a 1/n problem" addressable by de
- No empirical data on manipulation resistance
- High fees may reduce legitimate trading volume
### Additional Evidence (extend)
*Source: [[2024-01-24-futardio-proposal-develop-amm-program-for-futarchy]] | Added: 2026-03-16*
The proposal specifies the implementation: 'liquidity-weighted price over time. The more liquidity that is on the books, the more weight the current price of the pass or fail market is given. Every time there is a swap, these metrics are updated/aggregated.' This creates a continuous aggregation mechanism rather than point-in-time measurement.
---
Relevant Notes:

View file

@ -51,6 +51,8 @@ MetaDAO's token launch platform. Implements "unruggable ICOs" — permissionless
- **2024-06-14** — [[futardio-fund-rug-bounty-program]] passed: Approved $5K USDC funding for RugBounty.xyz platform development to incentivize community recovery from rug pulls
- **2024-08-28** — MetaDAO proposal to develop futardio as memecoin launchpad with futarchy governance failed. Proposal would have allocated $100k grant over 6 months to development team. Key features: percentage of each new token supply allocated to futarchy DAO, points-to-token conversion within 180 days, revenue distribution to $FUTA holders, immutable deployment on IPFS/Arweave. Proposal rejected by market, suggesting reputational risks outweighed adoption benefits.
- **2025-11-14** — Solomon launch: $8M raised (12.9x oversubscribed, $102.9M committed) for composable yield-bearing stablecoin
- **2024-08-28** — MetaDAO proposal to develop futardio (memecoin launchpad with futarchy governance) failed. Proposal included $100k grant over 6 months, Q3 launch target, and plan for immutable hyperstructure with $FUTA token distributing platform revenue to users and MetaDAO. Proposal explicitly framed memecoins as ideal futarchy use-case due to single objective function (token price).
- **2024-08-28** — MetaDAO proposal to develop futardio failed. Proposal would have allocated $100k grant over 6 months to build memecoin launchpad where percentage of each token supply goes to futarchy DAO, with points-to-token bootstrapping mechanism ($FUTA) and immutable hyperstructure deployment on IPFS/Arweave. Proposal explicitly framed as test of whether memecoin association would help or hurt futarchy adoption.
## Competitive Position
- **Unique mechanism**: Only launch platform with futarchy-governed accountability and treasury return guarantees
- **vs pump.fun**: pump.fun is memecoin launch (zero accountability, pure speculation). Futardio is ownership coin launch (futarchy governance, treasury enforcement). Different categories despite both being "launch platforms."

View file

@ -58,13 +58,14 @@ The futarchy governance protocol on Solana. Implements decision markets through
- **2024-03-02** — [[metadao-increase-meta-liquidity-dutch-auction]] passed: completed Dutch auction and liquidity provision, moving all protocol-owned liquidity to Meteora 1% fee pool
- **2025-01-27** — [[metadao-otc-trade-theia-2]] proposed: Theia offers $500K for 370.370 META at 14% premium with 12-month vesting
- **2025-01-30** — [[metadao-otc-trade-theia-2]] passed: Theia acquires 370.370 META tokens for $500,000 USDC
- **2023-11-18**[[metadao-develop-lst-vote-market]] proposed: first product development proposal requesting 3,000 META to build Votium-style validator bribe platform for MNDE/mSOL holders
- **2023-11-29**[[metadao-develop-lst-vote-market]] passed: approved LST Vote Market development with projected $10.5M enterprise value addition
- **2023-11-18** — metadao-develop-lst-vote-market proposed: first product development proposal requesting 3,000 META to build Votium-style validator bribe platform for MNDE/mSOL holders
- **2023-11-29** — metadao-develop-lst-vote-market passed: approved LST Vote Market development with projected $10.5M enterprise value addition
- **2023-12-03** — Proposed Autocrat v0.1 migration with configurable proposal slots and 3-day default duration
- **2023-12-13** — Completed Autocrat v0.1 migration, moving 990,000 META, 10,025 USDC, and 5.5 SOL to new program despite unverifiable build
- **2024-01-24** — Proposed AMM program to replace CLOB markets, addressing liquidity fragmentation and state rent costs (Proposal CF9QUBS251FnNGZHLJ4WbB2CVRi5BtqJbCqMi47NX1PG)
- **2024-01-29** — AMM proposal passed with 400 META on approval and 800 META on completion budget
- **2024-08-31** — Passed proposal to enter services agreement with Organization Technology LLC, creating US entity vehicle for paying contributors with $1.378M annualized burn rate. Entity owns no IP (all owned by MetaDAO LLC) and cannot encumber MetaDAO LLC. Agreement cancellable with 30-day notice or immediately for material breach.
- **2024-10-22** — Proposal to hire Advaith Sekharan as founding engineer passed with $180k/year salary and 237 META tokens (1% of supply) with performance-based unlocks starting at $500M market cap and full unlock at $5B, 4-year vest beginning November 2024, 8-month clawback period
## Key Decisions
| Date | Proposal | Proposer | Category | Outcome |
|------|----------|----------|----------|---------|

View file

@ -6,13 +6,9 @@ url: "https://www.futard.io/proposal/CF9QUBS251FnNGZHLJ4WbB2CVRi5BtqJbCqMi47NX1P
date: 2024-01-24
domain: internet-finance
format: data
status: enrichment
status: unprocessed
tags: [futardio, metadao, futarchy, solana, governance]
event_type: proposal
processed_by: rio
processed_date: 2026-03-16
enrichments_applied: ["amm-futarchy-reduces-state-rent-costs-by-99-percent-versus-clob-by-eliminating-orderbook-storage-requirements.md", "futarchy-clob-liquidity-fragmentation-creates-wide-spreads-because-pricing-counterfactual-governance-outcomes-has-inherent-uncertainty.md", "high-fee-amms-create-lp-incentive-and-manipulation-deterrent-simultaneously-by-making-passive-provision-profitable-and-active-trading-expensive.md", "liquidity-weighted-price-over-time-solves-futarchy-manipulation-through-capital-commitment-not-vote-counting.md", "amm-futarchy-bootstraps-liquidity-through-high-fee-incentives-and-required-proposer-initial-liquidity-creating-self-reinforcing-depth.md"]
extraction_model: "anthropic/claude-sonnet-4.5"
---
## Proposal Details
@ -132,14 +128,3 @@ Any important changes or feedback brought up during the proposal vote will be re
- Autocrat version: 0.1
- Completed: 2024-01-29
- Ended: 2024-01-29
## Key Facts
- MetaDAO Proposal #4 (CF9QUBS251FnNGZHLJ4WbB2CVRi5BtqJbCqMi47NX1PG) passed on 2024-01-24
- Proposal completed on 2024-01-29
- Budget: 400 META on passing + 800 META on completion
- CLOB minimum order size was 1 META as spam filter
- AMM implementation timeline: 3 weeks development + 1 week review
- Proposer: XXXvLz1B89UtcTsg2hT3cL9qUJi5PqEEBTHg57MfNkZ
- DAO account: 7J5yieabpMoiN3LrdfJnRjQiXHgi7f47UuMnyMyR78yy
- Autocrat version: 0.1

View file

@ -12,7 +12,7 @@ priority: medium
tags: [glp-1, medicare, obesity, budget-impact, CBO, federal-spending]
processed_by: vida
processed_date: 2026-03-16
enrichments_applied: ["federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md"]
enrichments_applied: ["federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md", "glp-1-multi-organ-protection-creates-compounding-value-across-kidney-cardiovascular-and-metabolic-endpoints.md"]
extraction_model: "anthropic/claude-sonnet-4.5"
---
@ -52,9 +52,8 @@ flagged_for_leo: ["Budget scoring methodology systematically disadvantages preve
## Key Facts
- CBO estimates Medicare coverage of anti-obesity medications would increase federal spending by $35 billion over 2026-2034
- ASPE estimates net savings of $715 million over 10 years from Medicare GLP-1 coverage (range: $412M to $1.04B)
- CBO estimates Medicare GLP-1 coverage would increase federal spending by $35 billion over 2026-2034
- ASPE estimates net savings of $715 million over 10 years (range: $412M to $1.04B across scenarios)
- Annual Part D cost increase projected at $3.1-6.1 billion
- Approximately 10% of Medicare beneficiaries would be eligible under proposed comorbidity-based criteria
- Broad semaglutide access projected to avoid 38,950 CV events and 6,180 deaths over 10 years
- Annual Part D cost increase from Medicare GLP-1 coverage: $3.1-6.1 billion
- Approximately 10% of Medicare beneficiaries would be eligible under proposed criteria requiring comorbidities
- Proposed eligibility criteria require CVD history, heart failure, CKD, or prediabetes—not just BMI threshold